Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis

ClinicalTrials.gov ID: NCT02406209

Public ClinicalTrials.gov record NCT02406209. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 3:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis

Study identification

NCT ID
NCT02406209
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Aldeyra Therapeutics, Inc.
Industry
Enrollment
45 participants

Conditions and interventions

Interventions

  • NS2 Drug
  • Prednisolone acetate ophthalmic suspension (1%) Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2015
Primary completion
Mar 31, 2016
Completion
Mar 31, 2016
Last update posted
Mar 26, 2023

2015 – 2016

United States locations

U.S. sites
15
U.S. states
12
U.S. cities
15
Facility City State ZIP Site status
Hull Eye Center Lancaster California 93534
Colorado Retina Associates,PC Golden Colorado 80401
Eye Center of Southern Connecticut Hamden Connecticut 06518-3144
Bascom Palmer Eye Institute Plantation Florida 33324
Valley Eye Physicians & Surgeons Ayer Massachusetts 01940
Ophthalmic Consultants of Boston Boston Massachusetts 02114
Massachusetts Eye Research and Surgery Institution (MERSI) Waltham Massachusetts 02451
Oakland Ophthalmic Surgery Birmingham Michigan 48009
Lifelong Vision Foundation Chesterfield Missouri 63017
Tauber Eye Center Kansas City Missouri 64111
UNMC Stanley Truhlsen Eye Institute Omaha Nebraska 68106
Metropolitan Eye Research & Surgery Institute Palisades Park New Jersey 07650
Mid-Atlantic Retina Philadelphia Pennsylvania 19107
Houston Eye Associates Houston Texas 77025
Virginia Eye Consultants Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02406209, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 26, 2023 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02406209 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →